Sanofi Bets Big On IO With Synthorx Buy

Expects Interleukin-2 To Be Foundation Of Future IO-IO Combos

 
• By Kevin Grogan
  
French flag
France's Sanofi building oncology franchise • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business